Gastroprokinetic agent, mosapride inhibits 5-HT(3) receptor currents in NCB-20 cells

Mosapride accelerates gastric emptying by acting on 5-hydroxytryptamine type 4 (5-HT(4)) receptor and is frequently used in the treatment of gastrointestinal (GI) disorders requiring gastroprokinetic efficacy. We tested the effect of mosapride on 5-hydroxytryptamine type 3 (5-HT(3)) receptor current...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yong Soo, Sung, Ki-Wug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717790/
https://www.ncbi.nlm.nih.gov/pubmed/31496879
http://dx.doi.org/10.4196/kjpp.2019.23.5.419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717790/
https://www.ncbi.nlm.nih.gov/pubmed/31496879
http://dx.doi.org/10.4196/kjpp.2019.23.5.419

Ejemplares similares